ERB-041
ERB-041 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
Study Evaluating ERB-041 in Active Crohn's Disease
Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Clinical Trials (6)
Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis
Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women
Study Evaluating ERB-041 in Active Crohn's Disease
Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6